NZ336371A - Human gene therapy using DNA/RNA cassette expression systems - Google Patents
Human gene therapy using DNA/RNA cassette expression systemsInfo
- Publication number
- NZ336371A NZ336371A NZ336371A NZ33637196A NZ336371A NZ 336371 A NZ336371 A NZ 336371A NZ 336371 A NZ336371 A NZ 336371A NZ 33637196 A NZ33637196 A NZ 33637196A NZ 336371 A NZ336371 A NZ 336371A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dna
- dna sequence
- gene therapy
- expression systems
- human gene
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Use of a recombinant DNA expression system comprising a 5' expression regulation DNA sequence and a decretory DNA and a secretory DNA sequence encoding a secretory signal sequence operatively linked to a DNA sequence encoding for therapeutic protein, peptide o antisense nucleotide selected from the group consisting of bacteriocins, lanthionins, lactoferrin and lysosyme, wherein said expression regulation DNA sequence and said secretory DNA sequence are capable of directing the in vivo expression of said DNA sequence of a therapeutically effective amount of said protein, peptide or antisense nucleotide as a active ingredient in a composition to prevent or treat an infectious disease in a human.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509461.1A GB9509461D0 (en) | 1995-05-10 | 1995-05-10 | DNA molecules and constructs and their use in the treatment of mastitis |
NZ307139A NZ307139A (en) | 1995-05-10 | 1996-05-10 | Method of genetically treating and preventing mastitis and other diseases in animals. |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ336371A true NZ336371A (en) | 2001-01-26 |
Family
ID=26307011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ336371A NZ336371A (en) | 1995-05-10 | 1996-05-10 | Human gene therapy using DNA/RNA cassette expression systems |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ336371A (en) |
-
1996
- 1996-05-10 NZ NZ336371A patent/NZ336371A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6787894A (en) | Adenoviral vectors of animal origin and use in gene therapy | |
CA2189250A1 (en) | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels | |
GR3030382T3 (en) | Cytokine restraining agents. | |
DE69434447D1 (en) | PLASMIDE FOR GENE THERAPY | |
GB2268492B (en) | Protein based delivery system | |
GB2292382B (en) | Obesity (OB) peptides capable of modulating body weight of animals, allelic variants, analogs and fragments thereof, derivatives, nucleic acid sequences, vect | |
MY132189A (en) | Recombinant obese (ob) proteins | |
MX9708854A (en) | Gene therapy for effector cell regulation. | |
WO2002044320A3 (en) | Human elongase genes and uses thereof | |
NZ334041A (en) | Anti-chlamydial activity of BPI (bactericidal/permeability increasing proteins) protein products against chlamydia infected host cells | |
WO1997022695A3 (en) | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer | |
HK1002284A1 (en) | Novel implant and novel vector for the treatment of acquired diseases | |
NZ336371A (en) | Human gene therapy using DNA/RNA cassette expression systems | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
WO1999046381A3 (en) | Human fgf gene and gene expression products | |
MX9604539A (en) | Modified amino acids for drug delivery. | |
ES2140307A1 (en) | Nucleic acids regulating gene expression. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: IMMUNOPHARMA INC, CA Free format text: OLD OWNER(S): 9071-7125 QUEBEC INC. |
|
RENW | Renewal (renewal fees accepted) |